Treatment Summary and Care Plan for Breast Cancer Survivors: acceptability and feasibility study
DOI:
https://doi.org/10.1590/1518-8345.7476.4621Keywords:
Breast Neoplasms; Cancer Survivors; Feasibility Studies; Patient Care Planning; Sickness Impact Profile; Medical OncologyAbstract
Objective: to evaluate the acceptability and feasibility of the Treatment Summary and Care Plan for Breast Cancer Survivors (TSSCP-P Br) document. Method: this was a cross-sectional, quantitative and qualitative study involving women who had completed treatment for breast cancer (n=50) and nurses (n=10) who incorporated the document into the care plan at outpatient follow-up appointments during the experimental phase of a clinical study. The feasibility and acceptability questionnaires were administered in the last data collection stage of the experiment. The data was analyzed using descriptive statistics and content analysis. Results: in the evaluation of the surviving women, feasibility showed retention of 98.0% and adherence of 99.3%. Acceptability in terms of suitability, convenience, efficacy and adherence reached 81.6%. From the professionals’ perspective, feasibility and acceptability were 84.2%, in terms of suitability, convenience, effectiveness, risks, availability, training, fidelity, reach and resources. The document was praised and the main problems in practice were pointed out, such as professional experience. Conclusion: the Treatment Summary and Care Plan proved to be feasible and acceptable for the clinical practice of caring for women who have survived breast cancer.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Revista Latino-Americana de Enfermagem
This work is licensed under a Creative Commons Attribution 4.0 International License.
RLAE’s authorship concept is based on the substantial contribution by each of the individuals listed as authors, mainly in terms of conceiving and planning the research project, collecting or analyzing and interpreting data, writing and critical review. Indication of authors’ names under the article title is limited to six. If more, authors are listed on the online submission form under Acknowledgements. The possibility of including more than six authors will only be examined on multicenter studies, considering the explanations presented by the authors.Including names of authors whose contribution does not fit into the above criteria cannot be justified. Those names can be included in the Acknowledgements section.
Authors are fully responsible for the concepts disseminated in their manuscripts, which do not necessarily reflect the editors’ and editorial board’s opinion.
